In the words of the late great, Steve Jobs, “Those who are crazy enough to think they can change the world usually do.” Well, we a GTC Consulting are that kind of crazy. On June 5th, 2018, GTC Consulting filed it’s first Drug Diversion and Counterfeit Prevention provisional patent application with the United States Patent and Trademark Office. After much thought and research, we have developed a true game changer that will help law enforcement quickly and easily identify counterfeit pharmaceutical drug products in the field. In addition, we are confident that this new non-obvious use invention will help stem the tide of the opioid epidemic and future drug abuse/misuse trends by helping investigators to quickly identify and stop the sources of drug diversion. In the past, it was nearly impossible to imagine a process where we could determine the origin of a single pill short of a confession or lengthy surveillance operation. In the near future, that will not be the case. Stay tuned!